title: Long term clinical outcome and bleeding complications among hospital survivors with acute coronary syndromes.
abstract: OBJECTIVE
  To examine the 21 month clinical outcome and bleeding complications in hospital survivors with non-ST segment elevation acute coronary syndromes (NSTEACS) who were discharged with combined clopidogrel and aspirin anti-thrombotic therapy, and compare with those having ST segment elevation myocardial infarction (STEMI) who were discharged with aspirin alone.
  
  
  METHODS
  Observational study.
  
  
  METHODS
  A large university hospital.
  
  
  METHODS
  224 patients were admitted to hospital with either NSTEACS or STEMI, and survived to discharge between 1 October 2001 and 31 December 2002.
  
  
  METHODS
  Cardiovascular death, total death, new myocardial infarction, unstable angina requiring hospitalisation, stroke or transient ischaemic attack, coronary revascularisation; and fatal, life threatening, major and minor bleeding over 21 months after discharge.
  
  
  RESULTS
  Despite having no or small infarct (median maximum creatine kinase 155 v 1295 u/l; p<0.001) and taking more antianginal drugs, patients with NSTEACS had similar rates of cardiovascular death (9.5% v 8.3%; p = NS), new myocardial infarction (9.5% v 6.5%; p = NS) or unstable angina requiring hospitalisation (15.5% v 10.2%; p = NS) when compared with STEMI. Fatal, life threatening or major bleeding were <1% in both groups (p = NS); and minor bleeding occurred in 4.3% NSTEACS and 2.8% STEMI patients respectively (p = NS).
  
  
  CONCLUSIONS
  Patients with NSTEACS had a similar and unfavourable long term outcome when compared with STEMI. There was no difference in serious bleeding complications between both groups.
authors.affiliation: Aintree Cardiac Centre, University Hospital Aintree, Liverpool, UK. peter.wong@aht.nwest.nhs.uk
authors.forename: P
authors.initials: P
authors.lastname: Wong
authors.forename: A
authors.initials: A
authors.lastname: Robinson
authors.forename: S
authors.initials: S
authors.lastname: Shaw
authors.forename: E
authors.initials: E
authors.lastname: Rodrigues
mesh_terms: D000208:Acute Disease; D000368:Aged; D003327:Coronary Disease / Q000188:drug therapy / Q000401:mortality*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006470:Hemorrhage / Q000209:etiology* / Q000401:mortality; D006760:Hospitalization / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality*; D011379:Prognosis
chemical_list: D005343:Fibrinolytic Agents